Gabapentin Tablet, Coated
Product Images NDC 68094-589

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68094-589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of Gabapentin showing its molecular arrangement with a cyclohexane ring bonded to an aminomethyl group and a carboxymethyl group.*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph showing mean pain score over an 8-week period with two groups: placebo and gabapentin 3,600 mg/day. The x-axis represents weeks, divided into a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain score from 0 to 9. Gabapentin group shows a decreasing pain score over time, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line graph showing mean pain score over a 7-week period in a clinical study. The x-axis represents weeks divided into a 3-week dose titration period and a 4-week fixed dose period, while the y-axis shows the mean pain score from 0 to 10. Three lines compare placebo, Gabapentin 1,800 mg/day, and Gabapentin 2,400 mg/day, illustrating trends in pain scores across these treatments.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar chart depicting two studies comparing the percentage response rates between placebo (PBO) and Gabapentin (GBP) at varying doses. Study 1 shows response rates of 12% for PBO and 29% for GBP at 3,600 mg. Study 2 shows response rates of 14% for PBO and higher rates for GBP at 1,800 mg (32%) and 2,400 mg (34%). Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot displaying percentage difference versus daily dose in mg. The chart compares three studies labeled a, b, and c at various daily doses ranging from 600 mg to 1,800 mg, with differences plotted between approximately 5% and 20%.*

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Label for Gabapentin Tablets USP, 600 mg coated tablets by Precision Dose, Inc. The label states storage instructions, dispensing guidance, and quantity of 100 tablets. NDC 68094-589-50 is visible along with barcodes and manufacturer details.*

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

Gabapentin Tablets USP 800 mg coated tablets label. The label includes dosage information, storage instructions, and a quantity of 100 tablets. The product is labeled by Precision Dose, Inc., with instructions for the pharmacist to dispense the medication guide. The label also shows an NDC number and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.